Project Grant 2304461
- Federal Cooperative Agreement Summary Inaedis, Inc. received a $1.25M Cooperative Agreement from the National Science Foundation (NSF) Technology, Innovation, and Partnerships program (CFDA 47.084), awarded June 1, 2025, with completion targeted for May 31, 2027. The award supports an SBIR Phase II project to develop and scale a Rapid Room-Temperature Aerosol Dehydration (RTAD) platform technology for stabilizing biopharmaceutical formulations at room temperature. This innovation addresses...
- This National Science Foundation (NSF) Small Business Technology Transfer (STTR) Phase I grant, awarded under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program, provides $274,991 to Duravax Inc. to develop thermostable formulations of mRNA vaccines and therapeutics. The project aims to overcome the cold-chain limitations of current mRNA products by demonstrating the feasibility of storing mRNA APIs and mRNA-lipid nanoparticles at room temperature for extended periods. If...
- Federal Project Grant Award Summary Award Details: Immuno Nano Med, Inc. received a $305,000 Phase I Small Business Technology Transfer (STTR) award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) on October 1, 2025, with completion targeted for September 30, 2026. The award supports research and development activities at the company's Ames, Iowa facility. Products and Services: This STTR Phase I project will develop and demonstrate...
- Federal Cooperative Agreement Summary Insu Health Design Inc. received a $998,527 Cooperative Agreement awarded on May 15, 2025, by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084). The award supports a Small Business Innovation Research (SBIR) Phase II project focused on developing and commercializing an advanced temperature control system for storing and transporting temperature-sensitive materials, including medications,...
- Federal Grant Award Summary Artyc PBC received a $305,000 Project Grant from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) awarded on June 1, 2025, with a completion date of May 31, 2026. This Small Business Technology Transfer (STTR) Phase I award funds the development of a novel magnetocaloric cooling system designed to replace conventional passive cooling methods in cold chain logistics for temperature-sensitive goods such...
- This Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program will fund research by Lyowave, Inc. to address the scale-up challenge for using high-frequency microwave heating in the manufacturing of freeze-dried medicines, diagnostics, and other sensitive materials. The $304,436 award aims to develop new experimental methods, physics-based models, and control strategies to enable the noninvasive retrofitting of...
- The National Science Foundation (NSF) awarded a $275,000 Small Business Innovation Research (SBIR) Phase I project grant to Agil Therapeutics Inc. under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084). This two-year project aims to develop a novel cryoablation system for minimally invasive treatment of type 2 diabetes. The system is designed to deliver a highly controlled and targeted cryogenic agent to the duodenum, with the goal of remodeling the duodenal tissue to...
- The National Science Foundation awarded Diant Pharma Inc. a $256,000 Project Grant under the Engineering (47.041) federal grant program. The grant will support development of an advanced continuous manufacturing system for nucleic acid lipid nanoparticles to improve supply chains for therapeutics and vaccines. Specifically, the small business innovation research Phase I project aims to create a compact, end-to-end manufacturing platform that follows current good manufacturing practices. This...
- The U.S. National Science Foundation (NSF) awarded a $980,360 Cooperative Agreement on April 1, 2025 under its Technology, Innovation, and Partnerships (CFDA 47.084) program to Startle Innovation LLC in Davis, CA. The project aims to develop a commercial prototype for a rapid food biomass dehydration process that utilizes zeolite filters to retain food nutrient profiles. The prototype will include a new desiccant filter, drying chamber, and microwave chamber. Key project objectives are to test...
- Global Cooling Technology Group LLC received a $296,000 Small Business Technology Transfer (STTR) Phase I Project Grant from the National Science Foundation under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084). The grant supports research and development of innovative two-phase cooling technologies using micro closed loop pulsating heat pipes for applications in high power density electronics. The STTR program aims to stimulate technological innovation through cooperative...
The National Science Foundation awarded a $275,000 STTR Phase I grant to Inaedis, Inc. to develop an innovative method for the thermal stabilization of biopharmaceutical formulations. The project aims to establish a rapid room-temperature aerosol dehydration (RTAD) process that improves the stability of biologics, vaccines, and other pharmaceuticals, circumventing the need for a cold chain supply. This technology seeks to serve international markets by allowing the pharmaceutical industry to avoid vulnerabilities associated with traditional cold chain systems, improving the safety, reliability, quality, and availability of vital medicines. The research and development will demonstrate the efficacy, reliability, and commercial applicability of the RTAD platform for dehydrating various protein and nucleic acid-based drug molecules while preserving their chemical and biological integrity. This STTR Phase I award reflects the NSF's mission to advance science and engineering research leading to breakthrough technologies that address national and societal challenges.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $275.0k | 9/14/23 |